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Abstract
Background: No clinical trials have been conducted in India on the efficacy of parenteral antibacterials to treat
footrot in sheep. In addition, there are no studies worldwide on the efficacy of parenteral antibacterials to treat
chronic footrot. Sixty two sheep with acute footrot and 30 sheep with chronic footrot from 7 villages in Kashmir,
India were recruited into two separate trials. Sheep with acute footrot were allocated to one of three treatments
using stratified random sampling: long acting parenteral oxytetracycline, long acting parenteral enrofloxacin and
topical application of potassium permanganate solution (a traditional treatment used by sheep farmers in India). In
a quasi pre-post intervention design, sheep with chronic footrot that had not responded to treatment with
potassium permanaganate were randomly allocated to treatment with one of the two parenteral antibacterials
mentioned above. Sheep with acute footrot were treated on day 0 and those with chronic footrot on days 0, 3, 6
and 9. Sheep were monitored for up to 28 days after treatment. Time to recovery from lameness and initial healing
of lesions was assessed using Kaplan-Meier survival curves, nonparametric log-rank and Wilcoxon sign-rank tests.
Results: There was significant correlation in recovery from lameness and presence of healing lesions in sheep with
acute (r = 0.94) or chronic (r = 0.98) footrot. Sheep with acute footrot which were treated with parenteral
antibacterials had a significantly more rapid recovery from lameness and had healing lesions (median = 7 days)
compared with those treated with topical potassium permanganate solution (less than 50% recovered in 28 days).
The median time to recovery in sheep with chronic footrot treated with either antibacterial was 17 days; this was
significantly lower than the median of 75 days lame before treatment with antibacterials. The median time to
recovery for both acute and chronic footrot increased as the severity of lesions increased. There was no difference
in time to recovery by age, body condition score, duration lame, or presence of pus in the foot within acute and
chronically affected sheep.
Conclusions: We conclude that use of parenteral antibacterials to treat sheep lame with either acute or chronic
footrot in India is highly effective. This is likely to improve welfare and give economic benefits to the farmers.
Background
India ranks sixth in the world in sheep production with
an estimated 61.5 million sheep [1]. Sheep farming is the
main livestock industry in northern hilly areas, such as
Kashmir, where it serves as a major source of income for
poor, rural communities who farm sheep for mutton and
wool. The system of sheep rearing in Kashmir is semi-
migratory. Flocks (20-30 sheep/flock) are kept housed by
owners for 4-5 months during winter. In spring, they are
grouped together with other flocks under the care of a
“chopan” (shepherd), who takes them to graze high alti-
tude sub-Himalayan and Himalayan pastures. In the
autumn, sheep are walked back to the valley mostly by
road and are returned to their owners [2].
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many countries including Australia, the UK, and New
Zealand. Footrot is caused by Dichelobacter nodosus [3].
The current understanding is that Dichelobacter nodosus
causes footrot. Other organisms, Fusobacterium necro-
phorum in particular, play an important role in facilitat-
ing the development of footrot according to some
authors [3] or increasing its severity according to others
[4]. Clinically, disease initially presents as an interdigital
dermatitis that can progress to separation of hoof horn
from the underlying sensitive tissue; there is a character-
istic foul smell with all stages of disease [3]. Footrot
lesions are acute when sheep have been lame for a short
period of time with the above characteristic clinical
signs but the foot has no chronic inflammation. Footrot
lesions are chronic when in addition to the characteris-
tic clinical signs, the hoof horn is thickened, mis-shapen
or overgrown with some degree of under-running [3,4].
Sheep with chronic lesions have been reported to be
lame for several weeks/months [3].
In the past few years footrot has become one of the big-
gest challenges for sheep farmers in Kashmir with a
reported prevalence of 13 to 16% [5] and an estimated
annual economic cost of approximately 37 million rupees
(equivalent to approximately 8.26 million US dollars) to
the sheep industry in south Kashmir [5]. Footrot spreads
between sheep when they are up on the Himalayan pas-
tures because of the warm, wet conditions [3] under foot
during the day and the high stocking densities at night
when sheep are grouped in paddocks to protect them
from predators.
Lame sheep are not treated until they return to the vil-
lages for the winter. The most common treatment for foo-
trot used by farmers in Kashmir is a topical application of
potassium permanganate solution (authors, personal com-
munication) to the lesion. There is no estimate of the effi-
cacy of this method but farmers indicated that despite this
treatment sheep are often lame with footrot for several
months or years (personal communication). Farmers state
that lame sheep are very unproductive and are often killed
because of this lack of productivity.
There is evidence from clinical trials in Australia that
treatment with short acting parenteral antibacterials such
as penicillin and streptomycin, lincomycin, lincospectin
and erythromycin [6-9] are effective against acute footrot
and efficacy is improved by provision of a dry environ-
ment for 24 hours after treatment [6]. There is evidence
from clinical trials in the UK that rapid recovery from
footrot occurs within 3-10 days of administering long
acting parenteral oxytetracycline without provision of a
dry environment [10,11].
The use of parenteral antibacterials to treat footrot is
not common in Kashmir and no clinical trials have been
conducted in India to investigate the efficacy of such
treatments for footrot. In addition, there have been no
studies internationally of the efficacy of parenteral anti-
bacterials to treat chronic footrot. The aim of the cur-
rent study was to investigate the efficacy of two long
acting parenteral antibacterials (oxytetracycline and
enrofloxacin) on the time to recovery from both acute
and chronic footrot lesions and the associated lameness
in sheep in the Kashmir region of India.
Methods
Study design
A clinical trial was conducted on seven farms with a
laboratory diagnosed history of footrot in Kashmir, north
India from December 2009 to May 2010. Sheep were
sourced from six private owners in the villages of Brinty
and Laroo in the Anantnag district and Fatehpora,
Wahidpora, Sailgam Saloora, and Shawlbugh in the Gan-
derbal district and finally from the Government Sheep
Breeding Farm, Goabal, also in the Ganderbal district.
Ninety two cross bred sheep with a minimum severity of
lameness of score 2, i.e. visible nodding of the head and
irregular stride but weight bearing on all four feet [12]
and with active footrot (a characteristic smell, inflamma-
tion of the interdigital space and possibly under-running
of hoof horn) were recruited into the trial. Their identifi-
cation, age (dentition), sex, body condition score, dura-
tion of lameness at recruitment (reported by farmers)
and the presence of pus in affected feet were recorded.
Footrot was categorized as chronic when there was an
active lesion with a characteristic foul smell plus hyper-
plasia of the sole and/or wall horn with some degree of
separation of the hoof from the underlying sensitive tis-
sue and the sheep had been lame for at least 28 days.
Footrot was considered acute when there was an active
lesion with characteristic foul smell, interdigital inflam-
mation with or without hoof horn separation, no hyper-
plasia of the sole and/or wall horn and the sheep had
been lame for less than 28 days. There were 62 sheep
with acute lesions and 30 sheep with chronic lesions.
The severity of footrot was scored using the system
described by Egerton and Roberts [13] on a scale of 1 to
4 (scores 1-2 early stages of footrot with mild to extensive
interdigital dermatitis and scores 3-4 extensive interdigi-
tal dermatitis plus under-running of hoof horn) for acute
lesions and lesion scores 3-4 for chronic lesions.
Sheep with acute and chronic footrot were compared in
two separate trials. In the first trial, sheep with acute foo-
trot were randomly allocated (stratified by maximum foo-
trot score), by drawing a coloured ball from a bag, to one
of two treatment groups: long acting oxytetracycline (n =
27) (200 mg/ml, dose rate: 1 ml/10 kg intramuscular
injection), long acting enrofloxacin (n = 25) (100 mg/ml,
dose rate: 7.5 mg/kg intramuscular injection) and a third
group was used as a control where 10 sheep (minimised
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Indian sheep farmers’ traditional treatment of topical
application of potassium permanganate solution. Sheep
received treatment on day 0, the day of diagnosis.
Researchers treated the first two groups and owner of the
sheep treated the third group.
The second trial was a quasi-experiment with a pre-post
treatment design [14]. Thirty sheep with chronic footrot,
previously treated with local topical treatment, were strati-
fied by maximum footrot score and then randomly allo-
cated, by drawing a coloured ball from a bag, to one of the
two antibacterial treatments (n = 13 (long acting oxytetra-
cycline); n = 17 (long acting enrofloxacin)) as described in
the first trial. Sheep were treated with antibacterials on
days 0, 3, 6 and 9.
For both the trials, antibacterials were sourced from a
reputable retailer and one batch number of each antibac-
terial type was used. The data were collected by one of 3
trained researchers who made all the observations on a
farm. Sheep were inspected by researchers on days 0, 1, 2,
3, 5, 7, 14, 17, 21 and 28 and locomotion and lesion scores
were recorded. A sheep recovered from lameness when it
was bearing weight on all four feet with no signs of uneven
posture or shortened stride (locomotion score 0) [12]. A
foot was considered recovered from acute or chronic foo-
trot when the lesion was not active: there was no foul
smell or exudate and there was healing, although the tis-
sue had not completely returned to normal.
The trial protocol was ethically approved by the Institu-
tional Ethical Committee of Faculty of Veterinary Sciences
and Animal Husbandry, SKUAST-K, Shuhama (Alusteng),
Srinagar, Jammu and Kashmir, India and informed con-
sent was obtained from the farmers.
Data analysis
Data were stored in Microsoft Access (Microsoft) and
Stata 10.0 SE (Statacorp, USA) was used for statistical ana-
lyses. Acute and chronically affected sheep were analysed
separately throughout. A Wilcoxon sign-rank test was
used to compare the duration of lameness in sheep with
chronic footrot pre and post treatment. The correlation
between time to recovery from lameness and lesions for
sheep with chronic or acute footrot was assessed using
Pearson’s correlation coefficients (r). Kaplan-Meier survi-
val curves and median time to recovery with 95% confi-
dence interval (CI) were calculated for each variable and a
log-rank test was used to compare equality of survivor
functions by category within a variable [15]; the log-rank
test for trend was conducted for ordered categories [16].
Pv a l u e s≤ 0.05 were considered significant.
Results
The distribution of acute and chronic footrot cases by
farm is presented in Table 1.
Trial I: acute footrot
There were 11 rams and 51 ewes with acute footrot. A
total of 56/62 sheep had one foot affected and six sheep
had 2 feet affected. All sheep, except eight, recovered from
footrot and lameness within 28 days: 6/8 sheep that did
not recover had been treated with topical potassium per-
manganate solution. Of the sheep that recovered, the med-
ian time to recovery from lesions and lameness was 7 days
(95% CI: 7-14). There was a very strong positive correla-
tion between recovery from lesions and lameness (r =
0.94, p < 0.05); all sheep recovered from lesions and lame-
ness at the same observation except three sheep with
acute footrot, which were lame for one week after recovery
from lesions. There was no significant difference in time to
recovery by the type of antibacterial used with sheep reco-
vering in a median time of 7 days (95% CI: 7-7) with both
antibacterials. However, sheep that were treated with a
topical application of potassium permanganate solution
were significantly less likely to recover (less than 50%
sheep recovered in the trial) in comparison with injectable
antibacterials (c
2 = 24.29, p < 0.001; Figure 1; Table 2).
Time to recovery increased significantly with the severity
of lesions (stratified by type of the treatment received) (c
2
trend = 19.72, p < 0.001). There was no significant differ-
ence in time to recovery by sex, farm, duration lame
before treatment, age, body condition score, or presence
of pus at diagnosis.
Trial II: chronic footrot
There were 30 ewes with chronic footrot; 27 had one
foot affected and three had two feet affected. There was
a significant difference (z = 4.78, p <0 . 0 1 )i nt h ed u r a -
tion of lameness before treatment (median = 75 days
(iqr (inter-quartile range): 60-135) and after parenteral
antibacterial administration (median = 17 days (iqr: 7-
28) (Figure 2). There was a very strong positive correla-
tion between recovery from lesions (recovery as defined
above) and lameness (r = 0.98; p < 0.05); there was only
one sheep with chronic footrot that was lame for one
week after lesions started to heal. There was no signifi-
cant difference in the duration of lameness by type of
antibacterial used (Table 2). All sheep, except three,
recovered from chronic footrot and lameness within 28
days of parenteral antibacterial treatment. Sheep with
chronic footrot had a significantly more rapid recovery
on two farms (SBF, Goabal and Brinte) (Table 2) with
sheep on these farms recovering in a median of 7 days
compared with 17-28 days on the other three farms.
As with sheep with acute footrot, the median time to
recovery from chronic footrot increased with lesion
severity: with a median time to recovery of 14 d and 21
d for lesion scores 3 and 4 respectively (Table 2; c
2 =
5.4, p < 0.05). There was no significant difference in
time to recovery after parenteral antibacterial treatment
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condition score, or presence of pus at diagnosis.
T h et i m et or e c o v e r y( m e d i a n=1 7d a y s )f o rs h e e p
with chronic footrot was significantly higher (c
2 = 19.48;
p < 0.01) than for sheep with acute footrot (median = 7
days). Sheep with chronic footrot had lower body condi-
tion scores (range 2 to 3) than sheep with acute footrot
(range 3 to 4). A significantly higher (50%) percentage
of sheep with chronic footrot had pus in the foot com-
pared with sheep with acute footrot (12%).
No sheep became lame again during the 28 day obser-
vation period in both the trials.
Discussion
This is the first clinical trial, to the authors’ knowledge,
to demonstrate recovery from chronic footrot and its
associated lameness. The rapid time to recovery with par-
enteral antibacterials is remarkable given that these sheep
had been lame from 28 days to two years. It does high-
light that systemic treatment with 12 days of therapeutic
level of antibacterials is highly effective against this bac-
terial disease, even for chronic lesions where sheep have
a persistent footrot lesion with hyperplasia and missha-
pen hoof horn [3,4]. Although sheep with chronic lesions
recovered from lameness and had no active footrot lesion
in the current study, we do not know whether or when
feet with hyperplastic horn returned to normal physical
conformation. Hoof horn damage takes several months
to resolve [3,17] and the follow up period for the current
trial was only 28 days, hence no information could be
collected on improvement in physical conformation.
There is evidence that sheep with poor foot shape are
more likely to improve their foot quality after treatment
with parenteral antibacterials [17].
There were no time parallel controls in the trial with
sheep with chronic footrot, instead, sheep acted as their
Table 1 Details of farms recruited for the clinical trial and number of sheep with acute and chronic footrot per farm
Farm number Village name District Number of acute cases Number of chronic cases Total number of sheep on farm
1 Fatehpora Ganderbal 9 0 15
2 Wahidpora Ganderbal 37 2 148
3 Saligam Ganderbal 9 0 35
4 Shawlbugh Ganderbal 6 3 35
5 SBF, Goabal Ganderbal 1 5 1050
6 Brinty Anantnag 0 9 140
7 Laroo Anantnag 0 11 65
Total 62 30 1488
Figure 1 Kaplan Meier survival curves of probability of recovery in sheep with acute footrot by type of treatment.
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design. These sheep had been lame for such a long time
and given local treatments so it seemed unethical to not
give these sheep the parenteral antibacterials that are
the best known treatment for footrot [10]. Quasi experi-
mental designs are widely used in medical and social
research where it is unethical to either withhold a treat-
ment that has known efficacy or where there is a need
to intervene quickly e.g. to prevent spread of infectious
disease [14]. There is a possibility of confounding by
factors that could have been different between the two
time periods (pre and post treatment) such as climate.
Climate has been shown to influence both the severity
and spread of footrot [3]. However, given that there was
a wide range of time in the duration of lameness it is
highly unlikely that recovery after treatment with anti-
bacterials occurred for any other reason than the treat-
ment given.
In Kashmir, there are many challenges faced by farmers
in managing footrot. Due to practical constraints, sheep
that develop footrot whilst on Himalayan pastures are
not treated until they return to the valley. They walk a
substantial distance to return home, usually on hard
roads that thicken and harden the hoof horn. Once
home, lame sheep are typically treated as described in the
introduction. Parenteral antibacterials are generally not
used; farmers have been told they are ineffective and
there are always concerns about the price and quality of
pharmaceuticals (authors, personal communication). The
results from the current trial indicate that if farmers use
a course of four long acting injections of a relatively inex-
pensive well sourced antibacterial, there will be welfare
benefits to the sheep and economic gain to the owners
b e c a u s eo n c et h e ya r en o tl a m ea n di np a i n[ 1 8 ]t h e s e
sheep will gain body condition and have improved con-
ception rates and lambing percentages [11]. There are
Table 2 Kaplan Meier estimates of median time to recovery with 95% confidence intervals (CI) for explanatory
variables in sheep by acute and chronic footrot
Variable Category Acute footrot Chronic footrot
N (% of all
affected)
Median time to recovery
(95% CI) in days
N (% of all
affected)
Median time to recovery
(95% CI) in days
Farm 1 9 (14) 7 (7-NE) -
2 37 (60) 7 (7-7) 2 (7) 17 (14-NE)
3 9 (14) 7 (3-NE) - -
4 6 (10) 7 (7-NE) 3 (10) 19 (14-NE)
5 1 (2) 2* 5 (16) 7 (6-NE)
6 - - 9 (30) 7 (7-NE)
7 - - 11 (37) 28 (17-28)
Age < 4 years 34 (57) 7 (7-7) 12 (40) 14 (7-21)
≥ 4 years 26 (43) 7 (7-7) 18 (60) 17 (7-28)
Presence of pus Yes 6 (10) 7 (5-7) 15 (50) 8 (7-28)
No 56 (90) 7 (7-7) 15 (50) 17 (8-21)
Body condition score 2 - - 16 (53) 7 (7-17)
3 52 (84) 7 (7-7) 14 (47) 21 (17-28)
4 10 (16) 7 (2-7) - -
Footrot severity Score 1 (acute) 9 (15) 3 (2-NE) - -
Score 2 (acute) 44 (70) 7 (7-7) - -
Score 3 (acute) 9 (15) 7 (5-14) - -
Score 3 (chronic) - - 21 (70) 14 (7-17)
Score 4 (chronic) - - 9 (30) 21 (7-NE)
No. of days lame
before treatment
Up to 1 wk 41 (66) 7 (7-7) - -
> 1 wk-27 days 21 (33) 7 (7-7) - -
> 27 days-2 months - - 13 (43) 14 (7-21)
> 2-8 months - - 10 (33) 17 (7-28)
> 8-24 months - - 7 (24) 7 (7-NE)
Treatment Oxytetracycline 28 (45) 7 (7-7) 12 (40) 17 (7-21)
Enrofloxacin 24 (39) 7 (7-7) 18 (60) 14 (7-28)
Topical treatment with potassium
permanganate solution
10 (16) ^ (21-NE) - -
*one observation; ^less than 50% sheep recovered; NE not estimated
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trot–either through neglect or inappropriate treatment.
There is every reason to consider that the treatment pre-
sented in the current study would be effective in resol-
ving footrot in these sheep.
As importantly, sheep with acute footrot recovered in a
median 7 days after treatment with antibacterials, similar
to other studies [10,11]. However, sheep that received the
traditional treatment of topical potassium permanganate
solution were lame for longer with only 4 recovering
within 28 days suggesting that this is an ineffective treat-
ment. A solution of potassium permanganate is generally
made at home by using the crystals that are readily avail-
able and cheap (authors’ personal communications). Its
use is common in these communities to disinfect water
and as a general antiseptic for human skin conditions at
concentration of 0.01% [19]. Factors such as the deep
seated location of D. nodous in footrot lesions [3] and/or
an incorrect concentration of the solution could have
contributed to low cure rates. It is possible that for very
mild cases of interdigital dermatitis topical application
leads to recovery. The lesions that received topical treat-
ment in the current study ranged from moderate interdi-
gital damage to some separation. There was no
information collected on the strength of solution used by
the farmers.
There was no significant difference between long act-
ing oxytetracycline and enrofloxacin on time to recovery
from footrot in the current trial. Enrofloxacin is a third
generation fluoroquinolone, a broad-spectrum bacterici-
dal antibacterial that is commonly used in veterinary
and human medicine in India [20]. It was used in the
current trial because of its common use and accessibility
in India. Given the global concern with the development
of antibacterial resistance with flouroquinolones [21,22]
and the fact that the long acting oxytetracycline was
equally effective, we consider that long acting oxytetra-
cycline, which is rarely used in human medicine, should
be used to treat sheep with acute or chronic footrot in
India.
In the current trial, sheep were followed for up to 10
days after recovery or a maximum of 28 days after treat-
ment. No sheep treated with parenteral antibacterials
became lame again during this period; however, we do
not know whether footrot recurred after the end of the
trial. Sheep with acute footrot with damaged feet and
poor foot integrity are more likely to get footrot again,
although this is less likely if they have been given par-
enteral antibacterials [17].
There was a significant association between lesion
severity and time to recovery from footrot in both acute
and chronic cases, with severe lesions with extensive
interdigital dermatitis and separation of horn taking
longer to heal. This is in contrast to other trials [9,10]
which reported no link between severity of lesions and
time to recovery. However, in Kaler et al. [10] and Jordan
et al. [9] the majority of the sheep (> 94%) had the most
severe lesion score (score 4), in addition, Kaler et al. [10]
Figure 2 Box plots of duration of lameness before and after treatment with parenteral antibacterials in sheep with chronic footrot.
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might have affected the results obtained.
Sheep in the current trial were scored by three trained
observers (with one observer making all the observations
per farm); this could have led to some observer bias. How-
ever, the same observer was used to score all the sheep
and follow up observations to minimize observer variabil-
ity. Unlike sheep with acute lesions where there was no
difference in recovery by farm, sheep with chronic lesions
had a significantly shorter time to recovery on two farms
compared with the other three farms. The sheep on each
of these farms were scored by two different observers. The
fact that these observers also scored acute cases and that
there was no differences in time to recovery by farm sug-
gests that this is less likely to be observer bias unless
observers were only biased when scoring recovery from
chronic lesions. Sheep on these two farms had lesion score
severities 3 and 4 and duration of lameness from 3 months
to 2 years which suggests the rapid recovery was unlikely
to be a confounding effect of severity of footrot or dura-
tion of lameness. There is a possibility that the treated
chronic cases on these two farms had better foot integrity
than other farms which led to rapid recovery [3,17], how-
ever, no information on foot integrity was recorded in this
trial to investigate this.
Conclusions
We conclude that parenteral antibacterials are an effec-
tive treatment for both acute and chronic footrot and
associated lameness in sheep in India. Their use to treat
s h e e pl a m ew i t hf o o t r o ti nK a s h m i rw o u l dv a s t l y
improve welfare of these sheep with considerable eco-
nomic benefit to the farmers.
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